Skip to main content
IVA logo

Inventiva S.A.

IVANASDAQHealthcareBiotechnology

$3.66Today:- (-)1Y −38.67%

As of Oct 26, 2026 close

Market cap
$1.00B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$2.82$7.98
Volume (live)
-
Avg. volume (3M)
3.06M

Inventiva (IVA) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Inventiva used EUR 100.98M of cash in operating activities and spent EUR 237.25K on capital expenditures. That left free cash flow of −EUR 101.22M.

Inventiva Cash Flow Statement Analysis

Values in millions EUR

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Inventiva S.A. (IVA) - Annual data in millions EUR
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Operating Activities
Net Income-340.16-184.21-110.43-54.27-49.64-33.62-30.22-33.62-17.23
Depreciation & Amortization3.225.202.601.70-1.291.891.582.321.42
Deferred Income Tax-2.30-4.80-4.74-5.26-3.27-7.65-4.30-4.72-7.87
Stock Based Compensation26.773.583.972.222.090.941.410.830.68
Change in Working Capital6.42-0.1214.125.710.98-1.97-0.770.972.55
Change in Accounts Receivable0.822.81-5.843.84-5.32-0.461.78-3.091.82
Change in Inventory0.000.42-0.040.02-0.070.070.020.030.00
Change in Accounts Payable2.46-3.3420.003.547.601.27-2.974.823.34
Change in Other Working Capital3.157.138.411.08-1.23-2.850.40-0.79-2.61
Other Operating Activities205.0782.50-0.281.083.509.833.890.013.45
Net Cash from Operating Activities-100.98-85.93-81.61-44.93-47.63-30.59-28.40-34.21-17.00
Investing Activities
Capital Expenditures-0.24-0.33-0.54-0.56-0.53-0.29-0.14-0.55-0.43
Acquisitions0.000.000.000.040.090.000.000.006.19
Purchases of Investments-127.699.08-7.320.00-1.35-8.27-0.690.000.15
Sales/Maturities of Investments0.009.080.989.39-0.090.000.690.130.27
Other Investing Activities0.009.08-7.329.390.090.00-0.690.020.00
Net Cash from Investing Activities-127.938.75-7.738.87-1.79-8.56-0.83-0.426.17
Financing Activities
Debt Repayment-5.98-2.61-2.49-1.77-0.039.89-0.15-0.26-0.15
Common Stock Issued237.74105.9728.088.8325.48101.788.6532.5345.16
Other Financing Activities0.2468.332.5930.21-0.020.00-0.130.000.00
Net Cash from Financing Activities232.00145.5929.0837.2725.45111.678.3832.2745.01
Summary
Effect of Forex Changes on Cash11.081.240.45-1.034.84-2.680.000.000.00
Net Change in Cash14.1769.65-59.821.21-19.1369.85-20.85-2.3634.18
Cash at Beginning of Period85.1026.9286.7486.55105.6935.8456.6959.0524.87
Cash at End of Period99.2796.5626.9286.7486.55105.6935.8456.6959.05
Free Cash Flow-101.22-86.26-82.15-45.49-48.16-30.88-28.54-34.76-17.43

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Inventiva Cash Flow

What is Inventiva's free cash flow?

Inventiva had negative free cash flow of EUR 101.22M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −EUR 100.98M minus EUR 237.25K of capital expenditures.

How much does Inventiva spend on capital expenditures?

Inventiva spent EUR 237.25K on capital expenditures in fiscal 2025, compared with EUR 333.00K a year earlier.

Does Inventiva pay dividends or buy back shares?

Inventiva's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition